Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 162

    1.

    Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia.

    Cohen RB, Abdallah JM, Gray JR, Foss F.

    Ann Intern Med. 1993 Jan 15;118(2):114-6. No abstract available. PMID: 8416307 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.

    Coso D, Costello R, Cohen-Valensi R, Sainty D, Nezri M, Gastaut JA, Bouabdallah R.

    Ann Oncol. 1999 Mar;10(3):362-3. No abstract available. PMID: 10355587 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fludarabine for chronic lymphocytic leukemia.

    Copur MS, Ledakis P, Muhvic J.

    N Engl J Med. 2001 Apr 12;344(15):1166; author reply 1167-8. No abstract available. PMID: 11302141 [PubMed - indexed for MEDLINE]Related articles

    4.

    Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP).

    Gonzalez H, Bolgert F, Camporo P, Leblond V.

    Hematol Cell Ther. 1999 Aug;41(4):183-6.PMID: 10543375 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effectiveness of fludarabine in advanced B-cell chronic lymphocytic leukemia.

    Montillo M, Tedeschi A, Delfini C, Olivieri A, D'Adamo F, Leoni P.

    Tumori. 1995 Nov-Dec;81(6):419-23.PMID: 8804467 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine]

    Kuliszkiewicz-Janus M, Małecki R, Kuliczkowski K, Jeleń M.

    Pol Arch Med Wewn. 2002 Sep;108(3):887-91. Polish. PMID: 12600186 [PubMed - indexed for MEDLINE]Related articles

    7.

    The role of fludarabine in hematological malignancies.

    Wright SJ, Robertson LE, O'Brien S, Plunkett W, Keating MJ.

    Blood Rev. 1994 Sep;8(3):125-34. Review.PMID: 7819814 [PubMed - indexed for MEDLINE]Related articles

    8.

    Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.

    Rashid K, Ng R, Mastan A, Sager D, Hirschman R.

    Leuk Lymphoma. 2005 Jul;46(7):1051-5.PMID: 16019557 [PubMed - indexed for MEDLINE]Related articles

    9.

    A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.

    Hocepied AM, Falkson CI, Falkson G.

    S Afr Med J. 1996 May;86(5):549-50.PMID: 8711555 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.

    Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA.

    N Engl J Med. 2000 Dec 14;343(24):1750-7.PMID: 11114313 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.

    Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA.

    Ann Oncol. 1992 Feb;3(2):171-2. No abstract available. PMID: 1606091 [PubMed - indexed for MEDLINE]Related articles

    12.

    Oral fludarabine: a viewpoint by Dieter Huhn.

    Huhn D.

    Drugs. 2003;63(21):2324. No abstract available. PMID: 14524734 [PubMed - indexed for MEDLINE]Related articles

    13.

    Purine analogs in the treatment of chronic lymphocytic leukemia.

    Pott C, Hiddemann W.

    Leukemia. 1997 Apr;11 Suppl 2:S25-8. Review.PMID: 9178834 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.

    Usman M, Adil SN, Sajid R, Khurshid M.

    J Pak Med Assoc. 2003 Oct;53(10):496-7. No abstract available. PMID: 14696895 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.

    Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y.

    Leuk Res. 2006 Dec;30(12):1589-90. Epub 2006 Mar 20.PMID: 16542723 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia]

    Léonard S, Hulin C, Anxionnat R, Grignon Y, Taillandier L, Vespignani H.

    Rev Neurol (Paris). 2002 Nov;158(11):1121-3. French. PMID: 12451348 [PubMed - indexed for MEDLINE]Related articles

    17.

    High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.

    Dungarwalla M, Evans SO, Riley U, Catovsky D, Dearden CE, Matutes E.

    Haematologica. 2008 Mar;93(3):475-6.PMID: 18310545 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.

    Leenders A, Sonneveld P, de Marie S.

    Eur J Clin Microbiol Infect Dis. 1995 Sep;14(9):826-8. No abstract available. PMID: 8536738 [PubMed - indexed for MEDLINE]Related articles

    19.

    Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia.

    Davidovitz Y, Ballin A, Meytes D.

    Acta Haematol. 1997;98(1):44-6.PMID: 9210914 [PubMed - indexed for MEDLINE]Related articles

    20.

    Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia.

    Stern SC, Shah S, Costello C.

    Br J Haematol. 1999 Sep;106(3):836-7. No abstract available. PMID: 10469479 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data